Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Department of Pathology and Laboratory Medicine, |
RCV001355339 | SCV001550203 | likely pathogenic | not provided | no assertion criteria provided | clinical testing | The FAM83H p.Leu793Cysfs*181 variant was not identified in the literature nor was it identified in dbSNP, ClinVar, Cosmic, MutDB or LOVD 3.0. The variant was not identified in the following control databases: the 1000 Genomes Project, the NHLBI GO Exome Sequencing Project, the Exome Aggregation Consortium (August 8th 2016), or the Genome Aggregation Database (Feb 27, 2017). The c.2377del variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at codon 793 and leading to a premature stop codon 181 codons downstream. This alteration is then predicted to result in a truncated or absent protein and loss of function. Loss of function variants of the FAM83H gene are an established mechanism of disease in Amelogenesis imperfecta, type IIIA and is the type of variant expected to cause the disorder. Further, MutationTaster predicts this variant to impact the protein. A study examining genotype-phenotype correlations in 5 families with FAM83H mutations causing autosomal-dominant hypocalcified amelogenesis imperfecta showed that the two families with FAM83H variants that left at least the first 694 amino acids intact had a less severe, localized form of the disorder (Wright_2009_PMID: 19407157). As this variant does not affect the first 793 amino acids of the protein, it may also be associated with a less severe form of the disorder. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more pathogenic role for this variant. This variant is classified as likely pathogenic. |